Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Patients with fluctuant peak expiratory flow value in the absent category are insensitive to dyspnea and are at risk for severe asthma exacerbation

Kumiya Sugiyama, Hirokuni Hirata, Naoya Ikeda, Taichi Shiobara, Masamitsu Tatewaki, Fumiya Fukushima, Masafumi Arima, Yasutsugu Fukushima, Takeshi Fukuda
European Respiratory Journal 2011 38: p922; DOI:
Kumiya Sugiyama
Pulmonary Medicine and Clinical Immunology, Dokkyo Medical University, Tochigi, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hirokuni Hirata
Pulmonary Medicine and Clinical Immunology, Dokkyo Medical University, Tochigi, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Naoya Ikeda
Pulmonary Medicine and Clinical Immunology, Dokkyo Medical University, Tochigi, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Taichi Shiobara
Pulmonary Medicine and Clinical Immunology, Dokkyo Medical University, Tochigi, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Masamitsu Tatewaki
Pulmonary Medicine and Clinical Immunology, Dokkyo Medical University, Tochigi, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fumiya Fukushima
Pulmonary Medicine and Clinical Immunology, Dokkyo Medical University, Tochigi, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Masafumi Arima
Pulmonary Medicine and Clinical Immunology, Dokkyo Medical University, Tochigi, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yasutsugu Fukushima
Pulmonary Medicine and Clinical Immunology, Dokkyo Medical University, Tochigi, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Takeshi Fukuda
Pulmonary Medicine and Clinical Immunology, Dokkyo Medical University, Tochigi, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

Exacerbation of asthma has a negative impact on quality of life and increases the risk of fatal asthma. One of the known risk factors of patients with a history of near-fatal asthma is experiencing mild asthmatic symptoms as opposed to airway obstruction. We set out to find patients carrying such a risk before they experience severe exacerbation of asthma.

To determine the character of such patients, we compared the background and asthma diaries (mean period, 274 days) of 53 asthma patients with their symptoms and peak expiratory flow value (PEF). According to the criteria of the Japanese Society of Allergology, symptoms were classified into 8 categories ranging in severity from absent to severe attack.

Average PEF was 75.2% (50.5–100) in absent, 64.5% (36.6–92.6) in wheeze, 57.3% (25.0–94.7) in mild attack and 43.6% (20.4–83.1) in moderate attack, and the personal best was 100%. Thus, differences in decreased PEF in cases with the same symptoms varied widely between patients. PEF in wheeze, mild and moderate attack did not correlate significantly with the duration of asthma, FEV1 or the proportion of personal best to standard PEF. These PEFs did not show a significant difference in the groups that were divided by regular treatment of asthma, but did show a significant negative correlation with the coefficient of variation of PEF when asthma was absent.

To reveal patients who are insensitive to dyspnea, the most important factor to consider is the coefficient of variation of PEF when asthma is absent. When we find such patients who exhibit fluctuant PEF, we have to intervene in their treatment, even when they claim to be stable.

  • © 2011 ERS
Previous
Back to top
Vol 38 Issue Suppl 55 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Patients with fluctuant peak expiratory flow value in the absent category are insensitive to dyspnea and are at risk for severe asthma exacerbation
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Patients with fluctuant peak expiratory flow value in the absent category are insensitive to dyspnea and are at risk for severe asthma exacerbation
Kumiya Sugiyama, Hirokuni Hirata, Naoya Ikeda, Taichi Shiobara, Masamitsu Tatewaki, Fumiya Fukushima, Masafumi Arima, Yasutsugu Fukushima, Takeshi Fukuda
European Respiratory Journal Sep 2011, 38 (Suppl 55) p922;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Patients with fluctuant peak expiratory flow value in the absent category are insensitive to dyspnea and are at risk for severe asthma exacerbation
Kumiya Sugiyama, Hirokuni Hirata, Naoya Ikeda, Taichi Shiobara, Masamitsu Tatewaki, Fumiya Fukushima, Masafumi Arima, Yasutsugu Fukushima, Takeshi Fukuda
European Respiratory Journal Sep 2011, 38 (Suppl 55) p922;
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo

Jump To

  • Article
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Freeflowmetry – The new method of evaluation of the respiratory function phenotype
  • Audit of a new mannitol challenge testing service in a UK tertiary centre
  • Evaluation of respiratory impedance in COPD by forced oscillation technique using a MostGraph
Show more 99. Monitoring with lung function tests in airway diseases

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society